Study Stopped
The investigative team has transferred to another university.
Investigating the Cognitive and Brain Health Benefits of Lean Pork Consumption
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The goal of this clinical trial is to learn if eating more lean pork will lead to better cognition and a healthier brain in older adults. The main questions it aims to answer are:
- Does eating more lean pork lead to higher scores on cognitive tests and better quality of life?
- Does eating more lean pork lead to slower brain aging and/or better brain function? Researchers will compare participants in the experimental group (participants undergoing the dietary intervention) to control participants (participants that do not undergo the intervention). Participants will:
- Be instructed to prepare and consume ready-to-eat pork meals along with their regular diet and not eat any more pork other than what they are given; or be instructed to consume their regular diet
- Visit the study facilities once every week to pick up ready-to-eat pork meals and complete dietary surveys; or complete dietary surveys every 4 weeks
- Visit the study facilities before and after the 16-week of intervention period for researchers to study them
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2025
CompletedFirst Posted
Study publicly available on registry
June 22, 2025
CompletedStudy Start
First participant enrolled
August 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
December 26, 2025
December 1, 2025
1.3 years
June 12, 2025
December 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (22)
WAIS-V
Wechsler Adult Intelligence Scale, verison 5. Comprehensive assessment battery for measuring cognitive abilities
Baseline and after 16 weeks
Trail Making Test
Delis-Kaplan Executive Function System test for sequencing and cognitive flexibility
Baseline and after 16 weeks
NIH Toolbox (Dimensional Change Card Sort)
Test for executive function and cognitive flexibility
Baseline and after 16 weeks
NIH Toolbox (Flanker)
test for executive functions: attention and inhibitory control
Baseline and after 16 weeks
NIH Toolbox (List Sorting Working Memory Test)
Test for working memory
Baseline and after 16 weeks
Adult Decision-Making Competence test
Assessment of how well adults make decisions. Subcategories include Resistance to Framing, Recognizing Social Norms, Under/Overconfidence, Applying Decision Rules, Consistency in Risk Perception, and Resistance to Sunk Costs
Baseline and after 16 weeks
Cognitive Reflection Test
Test to measure the ability to suppress an intuitive wrong answer in favor of a more reflective correct answer
Baseline and after 16 weeks
Attentional Network Task
Computerized task to measure the effects of visual and auditory cues on visual processing
Baseline and after 16 weeks
UCLA Loneliness Scale
measure of subjective loneliness and social isolation
Baseline and after 16 weeks
Short Form-36 Health Survey
self-report measure of health status and quality of life
Baseline and after 16 weeks
Psychological Wellbeing Scale
the psychological wellbeing scale assesses six aspects of psychological wellbeing and happiness: Autonomy, Environmental Mastery, Personal Growth, Positive Relations with Others, Purpose in Life, Self-Acceptance
Baseline and after 16 weeks
Decision Outcome Inventory
an assessment of outcomes of real-life decisions
Baseline and after 16 weeks
The Mindset Survey
an assessment to determine whether an individual has a fixed mindset or a growth mindset
Baseline and after 16 weeks
Need for Cognition Scale
assessment of an individual's tendency to engage in and enjoy thinking or mental exertion
Baseline and after 16 weeks
Pittsburgh Sleep Quality Index
Self-report assessment of sleep quality over the past month. The survey includes measures related to Sleep Latency, Sleep Duration, Sleep Efficiency, Sleep Disturbances, Use of Sleep Medications, Daytime Fatigue, and Sleep Quality
Baseline and after 16 weeks
Consortium to Establish a Registry for Alzhiemer's Disease Word List Acquisition and Delayed Recall
A learning and delay memory recall task that is used to quickly assess an individual's mental capacity in memory.
Baseline and after 16 weeks
Geriatric Depression Scale
Assessment of an older adult's status of mental health that screens for depression
Baseline and after 16 weeks
Ohio State Traumatic Brain Injury Identification
Interview-style assessment of past head injuries, including their severity and their resulting symptoms.
Baseline and after 16 weeks
Symptom Checklist 90-Revised
self-report assessment of psychological symptoms related to the domains of somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism
Baseline and after 16 weeks
Grit
self-report measure of perseverance
Baseline and after 16 weeks
Brief Dispositional Resilience Scale
a 15-item measure of psychological hardiness, covering aspects related to commitment, control, and challenge
Baseline and after 16 weeks
Valence Bias Task
an assessment to measure an individual's tendency to interpret ambiguous stimuli as having a positive or negative valence
Baseline and after 16 weeks
Secondary Outcomes (1)
Brain Imaging
Baseline and after 16 weeks
Other Outcomes (9)
Height
Baseline and after 16 weeks
Weight
Baseline and after 16 weeks
Body Mass Index
Baseline and after 16 weeks
- +6 more other outcomes
Study Arms (2)
Experimental Group
EXPERIMENTALThe experimental group will participate in the 16-week lean pork dietary intervention study. Participants will be provided with 4 portions of ready-to-eat lean pork in frozen packages per week. Each portion of ready-to-eat lean pork provided to this group will weigh 5 ounces.
Control Group
NO INTERVENTIONThe control group will not participate in any dietary intervention, other than being instructed to maintain their regular diet.
Interventions
The dietary intervention lasts 16 weeks for each individual. Participants in the experimental group will receive this intervention. Each participant will acquire 4 portions of ready-to eat lean pork in frozen packages per week; each portion of ready-to-eat lean pork in this intervention will weigh 5 ounces.
Eligibility Criteria
You may qualify if:
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
- Males and females; Age 65-75
- Willingness to adhere to the ready-to-eat lean pork intervention regimen or the control condition regimen (depending on group assignment)
- Score between 51 and 80 out of 100 on the Healthy Eating Index
- Consume less than or equal to 15 grams of lean pork per day on average prior to participating in the study
- BMI between 18.5 and 39.9
- Mini-Mental State Examination score 26 or greater
- Vision scored greater than 20/50
- No history of subjective cognitive impairment
- No evidence of loss of instrumental activities of daily living
- Minimal dependence in hygiene, bathing, and dressing
- Low pork consumers
- Willing to discontinue dietary supplement use throughout the duration of the study, if they are consuming supplement at the time of the registration
- No known contraindication to MRI scans as determined by the MRI screening survey questions
You may not qualify if:
- Current use of medications that may affect their responses to dietary intervention, such as amphetamines, antidepressants, anti-diabetic medications, laxatives, antibiotics, statins and diuretics.
- Known intolerance or allergy to pork
- Current use of nicotine products, including vaping
- Previous use of nicotine products, including vaping, within the recent 6 months at the time of pre-screening
- Diagnosis of mild cognitive impairment
- Diagnosis of any dementia, including, but not limited to, Alzheimer's Disease, Lewy body disease, vascular cognitive impairment and frontotemporal dementia
- Diagnosis of psychiatric illness within the last 3 years
- Stroke in previous 12 months
- Cancer diagnosis within past 3 years, except prostate cancer or basal cell carcinoma
- Current chemotherapy or radiation treatment
- Planned move from study area
- Scheduling conflicts that would preclude participation in study activities
- Prior or ongoing involvement in cognitive training or dietary intervention studies
- Contraindications for MRI
- Dietary quality outside the average range (i.e., HEI score less than 51 or greater than 80)
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Nebraska Lincolnlead
- National Pork Boardcollaborator
Study Sites (1)
University of Nebraska-Lincoln
Lincoln, Nebraska, 68588, United States
Related Publications (3)
Wade AT, Davis CR, Dyer KA, Hodgson JM, Woodman RJ, Keage HAD, Murphy KJ. A Mediterranean Diet with Fresh, Lean Pork Improves Processing Speed and Mood: Cognitive Findings from the MedPork Randomised Controlled Trial. Nutrients. 2019 Jul 4;11(7):1521. doi: 10.3390/nu11071521.
PMID: 31277446BACKGROUNDHepsomali P, Groeger JA. Diet and general cognitive ability in the UK Biobank dataset. Sci Rep. 2021 Jun 3;11(1):11786. doi: 10.1038/s41598-021-91259-3.
PMID: 34083695BACKGROUNDZhang H, Hardie L, Bawajeeh AO, Cade J. Meat Consumption, Cognitive Function and Disorders: A Systematic Review with Narrative Synthesis and Meta-Analysis. Nutrients. 2020 May 24;12(5):1528. doi: 10.3390/nu12051528.
PMID: 32456281BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aron Barbey, PhD
University of Nebraska Lincoln
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 12, 2025
First Posted
June 22, 2025
Study Start
August 1, 2025
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
December 26, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ANALYTIC CODE
- Time Frame
- IPD and supporting information will be available beginning 1 year after the publication of results with no end date.
- Access Criteria
- Researchers who provide a methodologically sound proposal will be able to access the IPD and supporting information. Researchers are not restricted on the type of analyses, as long as they are methodologically sound. The statistical methods for those analyses must be approved before the researchers can gain access to the data. For data sharing, a proposal that describes planned analyses must be submitted to the study's contact personnel for review. A data sharing agreement must be signed between the institution of the requesting researchers and the institution of the study's principal investigator.
Study findings will be submitted to peer-reviewed journals such as those that follow the ICMJE's recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. The data collected during this project may be shared through public-use files, repositories or other means outside of the approved research team as a requirement of publication. All data will be identified with subject IDs only when shared. Research records such as informed consent forms, MRI Safety Screening forms, research compliance records, masterlist linking names to subject IDs will not be shared.